The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity
Abstract
Context: Drug-drug interactions are a preventable cause of morbidity and mortality, yet their consequences in the community are not well characterized. Objective: To determine whether elderly patients admitted to hospital with specific drug toxicities were likely to have been prescribed an interacting drug in the week prior to admission. Design: Three population-based, nested case-control studies. Setting: Ontario, Canada, from January 1, 1994, to December 31, 2000. Patients: All Ontario residents aged 66 years or older treated with glyburide, digoxin, or an angiotensin-converting enzyme (ACE) inhibitor. Case patients were those admitted to hospital for drug-related toxicity. Prescription records of cases were compared with those of controls (matched on age, sex, use of the same medication, and presence or absence of renal disease) for receipt of interacting medications (co-trimoxazole with glyburide, clarithromycin with digoxin, and potassium-sparing diuretics with ACE inhibitors). Main Outcome Measure: Odds ratio for association between hospital admission for drug toxicity (hypoglycemia, digoxin toxicity, or hyperkalemia, respectively) and use of an interacting medication in the preceding week, adjusted for diagnoses, receipt of other medications, the number of prescription drugs, and the number of hospital admissions in the year preceding the index date. Results: During the 7-year study period, 909 elderly patients receiving glyburide were admitted with a diagnosis of hypoglycemia. In the primary analysis, those patients admitted for hypoglycemia were more than 6 times as likely to have been treated with co-trimoxazole in the previous week (adjusted odds ratio, 6.6; 95% confidence interval, 4.5-9.7). Patients admitted with digoxin toxicity (n = 1051) were about 12 times more likely to have been treated with clarithromycin (adjusted odds ratio, 11.7; 95% confidence interval, 7.5-18.2) in the previous week, and patients treated with ACE inhibitors admitted with a diagnosis of hyperkalemia (n = 523) were about 20 times more likely to have been treated with a potassium-sparing diuretic (adjusted odds ratio, 20.3; 95% confidence interval, 13.4-30.7) in the previous week. No increased risk of drug toxicity was found for drugs with similar indications but no known interactions (amoxicillin, cefuroxime, and indapamide, respectively). Conclusions: Many hospital admissions of elderly patients for drug toxicity occur after administration of a drug known to cause drug-drug interactions. Many of these interactions could have been avoided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
Use and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683
PROPORTION OF DISEASE CAUSED OR PREVENTED BY A GIVEN EXPOSURE, TRAIT OR INTERVENTION1
MIETTINEN, O. S. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121617 · Cited by 1,036 · cited 1×
“NSAIDs 510 (56) 21 636 (49) 558 (53) 23 941 (46) 295 (56) 12 945 (50)”
Reardon, L. C., & Macpherson, D. S. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.1.26 · Cited by 222
Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively
Wen, X., Wang, J.-S., Backman, J. T., Laitila, J., & Neuvonen, P. J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.6.631 · Cited by 173
ORCA: OpeRational ClassificAtion of Drug Interactions
Hansten, P. D., Horn, J. R., & Hazlet, T. K. (2001) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31244-x · Cited by 98
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Boyd, C. M., Darer, J., Boult, C., Fried, L. P., Boult, L., & Wu, A. W. (2005) · JAMA · doi:10.1001/jama.294.6.716 · Cited by 2,581
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
Juurlink, D. N., Mamdani, M. M., Lee, D. S., Kopp, A., Austin, P. C., Laupacis, A., & Redelmeier, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040135 · Cited by 1,761
Self-citationRodbard, H. W., Jellinger, P. S., Davidson, J. A., Einhorn, D., Garber, A. J., Grunberger, G., Handelsman, Y., Horton, E. S., Lebovitz, H., Levy, P., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.6.540 · Cited by 942
Gallagher, P., & O'Mahony, D. (2008) · Age and Ageing · doi:10.1093/ageing/afn197 · Cited by 697
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system
Palmer, B. F. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035279 · Cited by 640
Outpatient gatifloxacin therapy and dysglycemia in older adults.
Park-Wyllie, L. Y., Juurlink, D. N., Kopp, A., Shah, B. R., Stukel, T. A., Stumpo, C., Dresser, L., Low, D. E., & Mamdani, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055191 · Cited by 367
Self-citationNew Fibrate Use and Acute Renal Outcomes in Elderly Adults: A Population-Based Study
Zhao, Y. Y., Weir, M. A., Manno, M., Cordy, P., Gomes, T., Hackam, D. G., Juurlink, D. N., Mamdani, M., Moist, L., Parikh, C. R., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-8-201204170-00401 · Cited by 258
Self-citationThe clinical implications of ageing for rational drug therapy
Shi, S., Mörike, K., & Klotz, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0422-1 · Cited by 244
Considerations when prescribing trimethoprim-sulfamethoxazole
Ho, J. M. W., & Juurlink, D. N. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.111152 · Cited by 232
“This adverse effect generally manifests as a form of drug hypersensitivity syndrome, most commonly acute interstitial nephritis.(29) The classic findings include fever, rash and an elevated creatinine level.”
BackgroundSelf-citationDrug-Induced Hypoglycemia: A Systematic Review
Murad, M. H., Coto-Yglesias, F., Wang, A. T., Sheidaee, N., Mullan, R. J., Elamin, M. B., Erwin, P. J., & Montori, V. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1416 · Cited by 222
Drug interaction alert override rates in the Meaningful Use era: No evidence of progress
Bryant, A. D., Fletcher, G. S., & Payne, T. H. (2014) · Applied Clinical Informatics · doi:10.4338/aci-2013-12-ra-0103 · Cited by 172
Practitioners’ views on computerized drug-drug interaction alerts in the VA system
Ko, Y., Abarca, J., Malone, D. C., Dare, D. C., Geraets, D., Houranieh, A., Jones, W. N., Nichol, W. P., Schepers, G. P., & Wilhardt, M. (2007) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m2224 · Cited by 102
Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas
Parekh, T. M., Raji, M., Lin, Y.-L., Tan, A., Kuo, Y.-F., & Goodwin, J. S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.3293 · Cited by 75
Edrees, H., Amato, M. G., Wong, A., Seger, D. L., & Bates, D. W. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa034 · Cited by 64
Designing and evaluating contextualized drug–drug interaction algorithms
Chou, E., Boyce, R. D., Balkan, B., Subbian, V., Romero, A., Hansten, P. D., Horn, J. R., Gephart, S., & Malone, D. C. (2021) · JAMIA Open · doi:10.1093/jamiaopen/ooab023 · Cited by 34
Drug-induced endocrine disorders in the intensive care unit
Thomas, Z., Bandali, F., McCowen, K., & Malhotra, A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181dda0f2 · Cited by 30
Abbas, A., Al-Shaibi, S., Sankaralingam, S., Awaisu, A., Kattezhathu, V. S., Wongwiwatthananukit, S., & Owusu, Y. B. (2022) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-021-01346-8 · Cited by 29
Overlapping medication associated with healthcare switching among Korean elderly diabetic patients
Shin, J.-Y., Choi, N.-K., Jung, S.-Y., Kim, Y.-J., Seong, J.-M., & Park, B.-J. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.11.1461 · Cited by 24
A Population-Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin
Pincus, D., Gomes, T., Hellings, C., Zheng, H., Paterson, J. M., Mamdani, M. M., & Juurlink, D. N. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.171 · Cited by 18
Self-citationHughes, J. E., Bennett, K. E., & Cahir, C. (2024) · Clinical Drug Investigation · doi:10.1007/s40261-024-01369-9 · Cited by 13
High concurrent use of sulfonylureas and antimicrobials with drug interactions causing hypoglycemia
Pilla, S. J., Pitts, S. I., & Maruthur, N. M. (2022) · Journal of Patient Safety · doi:10.1097/pts.0000000000000739 · Cited by 12
Exploring the Utility of Automated Drug Alerts in Home Healthcare
Feldman, P. H., McDonald, M., Rosati, R. J., Murtaugh, C., Kovner, C., Goldberg, J. D., & King, L. (2006) · Journal for Healthcare Quality · doi:10.1111/j.1945-1474.2006.tb00592.x · Cited by 5
Metadata
- Authors
- Juurlink, D. N., Mamdani, M., Kopp, A., Laupacis, A., & Redelmeier, D. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-04-02
- Volume
- 289
- Issue
- 13
- Pages
- 1652
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2061075125
- Cited by
- 761
- References
- 7
- FWCI
- 18.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.